Boissel J.-P.,Novacare SAS |
Boissel J.-P.,Novadiscovery SAS |
Boissel J.-P.,CNRS Biometry and Evolutionary Biology Laboratory |
Boissel J.-P.,University Claude Bernard Lyon 1 |
And 12 more authors.
Although personalized medicine has been a subject of research and debate in recent years, it has been underused in medical practice, except in some cancers. We believe that the main reason for the gap between the potential of personalized medicine and its use in daily medical practice can be explained by the lack of an appropriate tool to facilitate the use of biomarker values in a doctors decision-making process. We propose that the effect model could form the basis of such a tool. © 2011 Future Medicine Ltd. Source